Family · Pharmaceutical analytical standards
Eplerenone
A selective mineralocorticoid receptor antagonist that blocks the action of aldosterone, approved in the United States in 2002 for hypertension and later also for heart failure after a heart attack. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It was developed as a more selective version of spironolactone: unlike the older drug, it has very little affinity for androgen, progesterone and glucocorticoid receptors.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
